Population Pharmacokinetic Modeling of Itraconazole and Hydroxyitraconazole for Oral SUBA-Itraconazole and Sporanox Capsule Formulations in Healthy Subjects in Fed and Fasted States

Benzer Materyaller

• Bioavailability of Single-Dose SUBA-Itraconazole Compared to Conventional Itraconazole under Fasted and Fed Conditions
  Yazar:: Rauseo, Adriana M., ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• 1354. Novel Formulation SUBA-Itraconazole in Fed and Fasted Healthy Volunteers: Expanding the Clinical Utility of the Established Mold Active Agent
  Yazar:: Lindsay, Julian, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Pharmacokinetics of Itraconazole and Hydroxyitraconazole in Healthy Subjects after Single and Multiple Doses of a Novel Formulation
  Yazar:: Mouton, J. W., ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• 2229. Relative Bioavailability of a Single Oral Dose of SUBA-Itraconazole 65 mg Capsule Compared with Conventional Itraconazole 100 mg Capsule Administered Under Fasted and Fed Conditions in Healthy Adult Volunteers
  Yazar:: Mudge, Stuart, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Intrapulmonary Pharmacokinetics and Pharmacodynamics of Itraconazole and 14-Hydroxyitraconazole at Steady State
  Yazar:: Conte, John E., ve diğerleri
  Baskı/Yayın Bilgisi: (2004)